HCPCS Level II drug code
J0694 — Injection, cefoxitin sodium, 1 gm
In short
J0694 is the HCPCS Level II code for injection, cefoxitin sodium, 1 gm. CMS assigns NDCs for Cefoxitin Sodium to it. The Medicare Part B payment limit is $5.416 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, cefoxitin sodium, 1 gm
- Short descriptor
- Cefoxitin sodium injection
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 1997
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J0694
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 15 NDCs to J0694 for Cefoxitin Sodium. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Cefoxitin Sodium | 00143-9876-10 | Hikma Pharmaceuticals USA Inc. | 10 × 1 | 100 |
| Cefoxitin Sodium | 00143-9877-25 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 50 |
| Cefoxitin Sodium | 00143-9878-25 | Hikma Pharmaceuticals USA Inc. | 25 × 1 | 25 |
| Cefoxitin Sodium | 00264-3123-11 | B. Braun Medical Inc. | 24 × 1 | 24 |
| Cefoxitin Sodium | 00264-3125-11 | B. Braun Medical Inc. | 24 × 1 | 48 |
| Cefoxitin Sodium | 25021-0109-10 | Sagent Pharmaceuticals | 10 × 1 | 10 |
| Cefoxitin Sodium | 25021-0110-20 | Sagent Pharmaceuticals | 10 × 1 | 20 |
| Cefoxitin Sodium | 25021-0111-99 | Sagent Pharmaceuticals | 10 × 1 | 100 |
| Cefoxitin Sodium | 44567-0245-25 | WG Critical Care, LLC | 25 × 1 | 25 |
| Cefoxitin Sodium | 44567-0246-25 | WG Critical Care, LLC | 25 × 1 | 50 |
| Cefoxitin Sodium | 44567-0247-10 | WG Critical Care, LLC | 10 × 1 | 100 |
| Cefoxitin Sodium | 63323-0341-25 | FreseniUS Kabi USA, LLC | 25 × 1 | 25 |
| Cefoxitin Sodium | 63323-0341-29 | FreseniUS Kabi USA, LLC | 25 × 1 | 25 |
| Cefoxitin Sodium | 63323-0342-25 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
| Cefoxitin Sodium | 63323-0342-29 | FreseniUS Kabi USA, LLC | 25 × 1 | 50 |
J0694: common questions
- Is J0694 a CPT code?
- No. J0694 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J0694?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 15 NDCs under J0694, for Cefoxitin Sodium. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J0694?
- $5.416 per 1 gm, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.